Key result
Pulmonary hypertension is consistently associated with increased mortality risk in all forms of left heart disease, except for aortic valve disease.
Why the study?
Does the presence of pulmonary hypertension predict hospitalisations for heart failure and mortality in patients with left heart disease?
Systematic Review
Does the presence of pulmonary hypertension predict hospitalisations for heart failure and mortality in patients with left heart disease?
Pulmonary hypertension is a consistent predictor of increased mortality and heart failure hospitalisation in patients with left heart disease.
Answers are grounded in this paper and cite their sources.
Supports incorporating pulmonary hypertension into risk stratification for left heart disease; confirms its consistent prognostic value across most subtypes.
OBJECTIVES: Left heart disease (LHD) is the main cause of pulmonary hypertension (PH), but little is known regarding the predictors of adverse outcome of PH associated with LHD (PH-LHD). We conducted a systematic review to investigate the predictors of hospitalisations for heart failure and mortality in patients with PH-LHD. DESIGN: Systematic review. DATA SOURCES: PubMed MEDLINE and SCOPUS from inception to August 2013 were searched, and citations identified via the ISI Web of Science. STUDY SELECTION: Studies that reported on hospitalisation and/or mortality in patients with PH-LHD were included if the age of participants was greater than 18 years and PH was diagnosed using Doppler echocardiography and/or right heart catheterisation. Two reviewers independently selected studies, assessed their quality and extracted relevant data. RESULTS: In all, 45 studies (38 from Europe and USA) were included among which 71.1% were of high quality. 39 studies were published between 2003 and 2013. The number of participants across studies ranged from 46 to 2385; the proportion of men from 21% to 91%; mean/median age from 63 to 82 years; and prevalence of PH from 7% to 83.3%. PH was consistently associated with increased mortality risk in all forms of LHD, except for aortic valve disease where findings were inconsistent. Six of the nine studies with data available on hospitalisations reported a significant adverse effect of PH on hospitalisation risk. Other predictors of adverse outcome were very broad and heterogeneous including right ventricular dysfunction, functional class, left ventricular function and presence of kidney disease. CONCLUSIONS: PH is almost invariably associated with increased mortality risk in patients with LHD. However, effects on hospitalisation risk are yet to be fully characterised; while available evidence on the adverse effects of PH have been derived essentially from Caucasians.
No takes yet. Share an insight, caveat, or question.
Dzudié et al. (2014) conducted a systematic review in Pulmonary hypertension associated with left heart disease. Pulmonary hypertension was evaluated on Hospitalisations for heart failure and mortality. Pulmonary hypertension is consistently associated with increased mortality risk in all forms of left heart disease, except for aortic valve disease.
Synapse has enriched 10 related papers. Consider them for comparative context: